SUNDAY, FEBRUARY 15
AFTERNOON COURSES | 2:00 – 5:00 pm
SC1: Translating CTCs to Clinical Use
Joshua M. Lang, M.D., MS, Assistant Professor of Medicine, Carbone Cancer Center, University of Wisconsin, Wisconsin Institutes for Medical Research
Allison Welsh, Ph.D., CTC Scientist, Foundation Medicine, Inc.
Benjamin Casavant, Ph.D., Vice President, Tasso
SC2: Latest Advances in Molecular Pathology
Iris Schrijver, M.D., Professor of Pathology and Pediatrics; Director, Molecular Pathology Laboratory, Stanford University Medical Center, Lucile Packard Children’s Hospital
Michael H.A. Roehrl, M.D., Ph.D., Director, UHN Program in BioSpecimen Sciences, University of Toronto
SC3: Validation and Compliance Considerations for an NGS Lab
Victoria M. Pratt, Ph.D., FACMG, Director, Pharmacogenomics Laboratory, Medical and Molecular Genetics, Indiana University School of Medicine
Monica J. Basehore, Ph.D., FACMG, Lead Director, Molecular Diagnostic Laboratory; Associate Director, Medical Genetics Training Program, Greenwood Genetic Center
SC4: Sequencing 101
Ryan Kim, Ph.D., Director, UC Davis Genome Center, DNA Technologies and Expression Analysis Cores, University of California, Davis
SC5: PCR Part I: Primer Design for PCR Experiments
Jian Han, Ph.D., Faculty Investigator, iCubate, HudsonAlpha Institute for Biotechnology
Carl T. Wittwer, M.D., Ph.D., Professor, Pathology, University of Utah
SC6: Reimbursement for Advanced Diagnostics: From Clinical Value Establishment to Coverage and Pricing
Catherine Schnabel, Ph.D., Senior Vice President, Research & Development, bioTheranostics, Inc.
Macey Johnson III, Vice President, Managed Care and Reimbursement, bioTheranostics, Inc.
Frieda Gerdes, Managing Director, Management, Gerdes Healthcare Communication UG
DINNER COURSES | 5:30 – 8:30 pm
SC9: Clinical Informatics Needs Co-Organized with of an NGS Lab
Alexis B. Carter, M.D., Assistant Professor, Pathology and Laboratory Medicine; Member, Center for Comprehensive Informatics; Director, Pathology Informatics, Emory University School of Medicine; Chair, AMP Informatics Interest Group; President, Association of Pathology Informatics
Federico A. Monzon, M.D., FCAP, Director, Oncology, InVitae; Adjunct Faculty, Baylor College of Medicine
Mark J. Routbort, M.D., Ph.D., Director, Computational and Integrational Pathology; Associate Professor, Hematopathology; Medical Director, Laboratory Informatics, UT MD Anderson Cancer Center
SC10: Knowing Your NGS Analysis Upstream: Alignments and Variants
Gabe Rudy, Vice President, Product Development, Golden Helix
SC11: Regulatory Compliance in Molecular Diagnostics
Pamela L. Swatkowski, Director, Regulatory Affairs, Abbott Molecular, Inc.
Melina Cimler, Ph.D., Vice President, Head, Global Quality, Illumina, Inc.
SC12: Introduction to Hadoop for Bioinformatics
Martin Gollery, CEO, Tahoe Informatics
SC13: PCR Part II: Digital PCR Applications and Advances
Alison Devonshire, Ph.D., Science Leader, Nucleic Acid Metrology, LGC Genomics
Robert Palais, Ph.D., Associate Professor, Math Dept, Utah Valley University; Research Professor, Pathology Dept, University of Utah
MONDAY, FEBRUARY 16
MORNING COURSES | 8 – 11:00 am
SC17: Commercialization Boot Camp: Manual for Success in Molecular Diagnostics
Harry Glorikian, Healthcare Consultant
Elaine Cheung, Business & Corporate Development, Illumina
SC18: Next-Generation Sequencing as a Diagnostics Platform
Karl Voelkerding, M.D., Associate Professor, Pathology, University of Utah; Medical Director, Advanced Technology and Bioinformatics, ARUP Laboratories
Additional Instructors to be Announced
SC19: Isolation and Characterization of Cancer Stem Cells
Leslie Crews, Ph.D., Assistant Project Scientist, Catriona Jamieson Laboratory, Sanford Consortium for Regenerative Medicine and MooresUCSD Cancer Center
Kristen M. Smith, Ph.D., Scientist II, Bionomics, Inc.
SC20: Using Preclinical Models in Oncology to Inform First-Man-Trial Design: Tools and Techniques
Arijit Chakravarty, Ph.D., Director, Modeling & Simulation (DMPK), Takeda Pharmaceutical International Co.
SC21: Best Practices in Personalized and Translational Medicine
Erik Bierwagen, Principal Programmer Analyst, Genentech Sergio Rotstein, Ph.D., Director, Research Business Technology, Pfizer, Inc.
Jean Yuan, Senior Programming Analyst, Genentech Doug Garrett, Software Engineer, Genentech
SC22: NGS for Infectious Disease Diagnostics
Speaker to be Announced, Lab of Charles Chiu, M.D., Ph.D., University of California San Francisco
* Separate Registration Require or All Access Registration.